Brief: MGC Pharmaceuticals Ltd Says Faced Difficulties In Raising Funds In UK Primarily, And In Australia
Sept 26 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* MGC PHARMACEUTICALS LTD - BOARD AND MANAGEMENT HAVE BEEN
FORCED
TO TAKE DECISIVE ACTION AND DESIGN A RESTRUCTURING PLAN
* MGC PHARMACEUTICALS LTD - PLAN WILL REDUCE OUR RELIANCE ON
CONSTANT CAPITAL RAISING AND ALLOW US TO COMPLETE AN 18-MONTH
WORK PLAN
* MGC PHARMACEUTICALS LTD - FACED EXTREME DIFFICULTIES IN
RAISING
FUNDS IN UK PRIMARILY, AND IN AUSTRALIA
Source text for Eikon: ID:nRSZ6570Na
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program